Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin
CompletedOBSERVATIONAL
Enrollment
10
Participants
Timeline
Start Date
August 2, 2013
Primary Completion Date
January 13, 2017
Study Completion Date
January 13, 2017
Conditions
Chronic Hepatitis C
Trial Locations (1)
00927
Fundacion de Investigacion de Diego, San Juan
All Listed Sponsors
collaborator
Santaris Pharma A/S
INDUSTRY
lead
Hoffmann-La Roche
INDUSTRY
NCT02508090 - Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin | Biotech Hunter | Biotech Hunter